Details

Title
Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system
Author
Ilinykh, Philipp A. 1 ; Huang, Kai 1   VIAFID ORCID Logo  ; Gunn, Bronwyn M. 2   VIAFID ORCID Logo  ; Kuzmina, Natalia A. 1   VIAFID ORCID Logo  ; Kedarinath, Kritika 1 ; Jurado-Cobena, Eduardo 1   VIAFID ORCID Logo  ; Zhou, Fuchun 1 ; Subramani, Chandru 1 ; Hyde, Matthew A. 3 ; Velazquez, Jalene V. 4 ; Williamson, Lauren E. 5   VIAFID ORCID Logo  ; Gilchuk, Pavlo 5 ; Carnahan, Robert H. 6   VIAFID ORCID Logo  ; Alter, Galit 2 ; Crowe, James E. 7   VIAFID ORCID Logo  ; Bukreyev, Alexander 8   VIAFID ORCID Logo 

 University of Texas Medical Branch, Department of Pathology, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964); Galveston National Laboratory, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964) 
 Ragon Institute of MGH, MIT and Harvard, Cambridge, USA (GRID:grid.461656.6) (ISNI:0000 0004 0489 3491) 
 Galveston National Laboratory, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964) 
 Washington State University, Paul G. Allen School of Global Health, Pullman, USA (GRID:grid.30064.31) (ISNI:0000 0001 2157 6568) 
 Vanderbilt University Medical Center, Vanderbilt Vaccine Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916) 
 Vanderbilt University Medical Center, Vanderbilt Vaccine Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916); Vanderbilt University Medical Center, Department of Pediatrics, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916) 
 Vanderbilt University Medical Center, Vanderbilt Vaccine Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916); Vanderbilt University Medical Center, Department of Pediatrics, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916); Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916) 
 University of Texas Medical Branch, Department of Pathology, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964); Galveston National Laboratory, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964); University of Texas Medical Branch, Department of Microbiology and Immunology, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964) 
Pages
921
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3086478478
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.